Luo et al. 's study found that grifolin can induce the expression of DAPK1 in nasopharyngeal cancer, breast cancer and colon cancer cell lines, thereby targeting the regulation of P53 protein to induce apoptosis of cancer cells. The gene discussed is TP53; the disease is breast cancer.